Association between GLP-1 receptor agonist use and NAION with optic disc drusen.
Where this comes from
- Record sourced from PubMed, PMID 42302889.
- Also identified by DOI 10.1016/j.ophtha.2026.06.014.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In adults with optic disc drusen and type-2-diabetes or obesity, glucagon-like peptide-1 receptor agonists exposure was not associated with increased nonarteritic anterior ischemic optic neuropathy hazard, though moderate risk increases could not be excluded statistically.